Guangxi LiuYao Group Co., Ltd (SHA:603368)
China
· Delayed Price · Currency is CNY 17.28
-0.01 (-0.06%)
Jul 11, 2025, 2:45 PM CST
Guangxi LiuYao Group Revenue
Guangxi LiuYao Group had revenue of 5.32B CNY in the quarter ending March 31, 2025, a decrease of -7.93%. This brings the company's revenue in the last twelve months to 20.72B, down -2.48% year-over-year. In the year 2024, Guangxi LiuYao Group had annual revenue of 21.18B with 1.78% growth.
Revenue (ttm)
20.72B
Revenue Growth
-2.48%
P/S Ratio
0.33
Revenue / Employee
3.76M
Employees
5,513
Market Cap
6.89B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.18B | 370.55M | 1.78% |
| Dec 31, 2023 | 20.81B | 1.76B | 9.23% |
| Dec 31, 2022 | 19.05B | 1.92B | 11.19% |
| Dec 31, 2021 | 17.13B | 1.47B | 9.36% |
| Dec 31, 2020 | 15.67B | 811.84M | 5.46% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |